Skip to main content
. 2016 Jun 21;22(23):5400–5405. doi: 10.3748/wjg.v22.i23.5400

Table 4.

Adverse events (CTC AE3.0)

Patient I°-II° III°-IV° Total
Fatigue 70% (7/10) 30% (3/10) 100%
Nausea 20% (2/10) 0% (0/10) 20%
Emesis 20% (2/10) 10% (1/10) 30%
Diarrhea 40% (4/10) 0% (0/10) 40%
Mukositis 30% (3/10) 10% (1/10) 40%
Rash 20% (2/10) 0% (0/10) 20%
HFS 30% (3/10) 0% (0/10) 30%
PNP 20% (2/10) 0% (0/10) 20%
Pain 20% (2/10) 10% (1/10) 30%
Weight loss 10% (1/10) 0% (0/10) 10%
Infection 20% (2/10) 0% (0/10) 20%
Anemia 40% (4/10) 20% (2/10) 60%
Thrombopenia 30% (3/10) 10% (1/10) 40%
Leucopenia 20% (2/10) 10% (1/10) 30%